Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies ​are expected to go public amid a ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Why will pharma CEOs be greeted warmly in San Francisco next week? And who will buy Revolution Medicines? All that and more ...

This week on "The Readout LOUD," a special live taping from #JPM26 featuring new Novo Nordisk CEO Mike Doustdar and biotech ...

Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy ...

Business and education leaders gathered to discuss how Boston can maintain its competitive edge as other regions make ...

A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, ...

Biotech companies that will lead the next decade wont just have better science, theyll have superior operating models, writes ...

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).